8.27
price up icon0.73%   0.06
after-market 시간 외 거래: 8.27
loading
전일 마감가:
$8.21
열려 있는:
$8.26
하루 거래량:
127.66K
Relative Volume:
0.46
시가총액:
$402.20M
수익:
$62.02M
순이익/손실:
$-45.65M
주가수익비율:
0.728
EPS:
11.36
순현금흐름:
$-9.60M
1주 성능:
-4.39%
1개월 성능:
+2.10%
6개월 성능:
-12.58%
1년 성능:
-16.04%
1일 변동 폭
Value
$8.139
$8.30
1주일 범위
Value
$8.139
$8.65
52주 변동 폭
Value
$7.44
$11.71

Theravance Biopharma Inc Stock (TBPH) Company Profile

Name
명칭
Theravance Biopharma Inc
Name
전화
650-808-6000
Name
주소
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Name
직원
99
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
TBPH's Discussions on Twitter

Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-05-23 개시 SVB Leerink Outperform
2021-11-05 업그레이드 JP Morgan Underweight → Neutral
2021-09-15 다운그레이드 JP Morgan Overweight → Underweight
2021-08-25 다운그레이드 Morgan Stanley Overweight → Underweight
2021-08-24 다운그레이드 Cowen Outperform → Market Perform
2020-10-14 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-07-07 개시 JP Morgan Overweight
2020-06-15 개시 Morgan Stanley Equal-Weight
2020-05-13 개시 Cowen Outperform
2020-01-08 재확인 H.C. Wainwright Buy
2019-11-06 업그레이드 Robert W. Baird Underperform → Neutral
2019-10-29 개시 H.C. Wainwright Buy
2018-03-29 재개 Piper Jaffray Overweight
2017-08-17 개시 Evercore ISI Outperform
2017-06-16 개시 Cantor Fitzgerald Overweight
2017-05-11 재확인 Needham Buy
2016-12-21 개시 Needham Buy
2016-11-03 개시 Piper Jaffray Overweight
2016-10-12 다운그레이드 Robert W. Baird Neutral → Underperform
2016-08-03 다운그레이드 BofA/Merrill Neutral → Underperform
2016-06-20 개시 Guggenheim Buy
2016-06-20 재확인 Leerink Partners Outperform
2016-05-12 개시 Leerink Partners Outperform
2016-05-05 다운그레이드 BofA/Merrill Buy → Neutral
2015-02-03 업그레이드 Robert W. Baird Underperform → Neutral
모두보기

Theravance Biopharma Inc 주식(TBPH)의 최신 뉴스

pulisher
10:37 AM

Theravance Biopharma (TBPH) Scheduled to Post Earnings on Tuesday - MarketBeat

10:37 AM
pulisher
03:51 AM

Vanguard Group Inc's Strategic Acquisition in Theravance Biophar - GuruFocus.com

03:51 AM
pulisher
Nov 04, 2024

(TBPH) Proactive Strategies - Stock Traders Daily

Nov 04, 2024
pulisher
Oct 26, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Sold by SG Americas Securities LLC - MarketBeat

Oct 26, 2024
pulisher
Oct 24, 2024

When (TBPH) Moves Investors should Listen - Stock Traders Daily

Oct 24, 2024
pulisher
Oct 24, 2024

Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan

Oct 24, 2024
pulisher
Oct 23, 2024

Q3 EPS Estimate for Theravance Biopharma Boosted by Analyst - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Brokerages Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $13.75 - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

What is Zacks Research's Estimate for TBPH Q4 Earnings? - MarketBeat

Oct 22, 2024
pulisher
Oct 20, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Average Rating of "Hold" by Analysts - MarketBeat

Oct 20, 2024
pulisher
Oct 20, 2024

The Manufacturers Life Insurance Company Decreases Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

Oct 20, 2024
pulisher
Oct 19, 2024

Theravance study shows YUPELRI improves COPD lung function By Investing.com - Investing.com Australia

Oct 19, 2024
pulisher
Oct 19, 2024

Theravance Biopharma (NASDAQ:TBPH) Shares Pass Below 200 Day Moving AverageHere's What Happened - MarketBeat

Oct 19, 2024
pulisher
Oct 18, 2024

Theravance study shows YUPELRI improves COPD lung function - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease - StockTitan

Oct 18, 2024
pulisher
Oct 14, 2024

Where are the Opportunities in (TBPH) - Stock Traders Daily

Oct 14, 2024
pulisher
Oct 11, 2024

Dimensional Fund Advisors LP Has $2.80 Million Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

Theravance Biopharma (STU:0TB) Price-to-Operating-Cash-Flow : (As of Oct. 10, 2024) - GuruFocus.com

Oct 10, 2024
pulisher
Oct 07, 2024

Squarepoint Ops LLC Takes $986,000 Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat

Oct 07, 2024
pulisher
Oct 06, 2024

Bank of Montreal Can Raises Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat

Oct 06, 2024
pulisher
Oct 04, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Stock Holdings Lifted by Marshall Wace LLP - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

(TBPH) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Oct 03, 2024
pulisher
Oct 02, 2024

XTX Topco Ltd Purchases New Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

Oct 02, 2024
pulisher
Sep 28, 2024

Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y - MSN

Sep 28, 2024
pulisher
Sep 25, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Rhumbline Advisers Sells 15,095 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

Sep 25, 2024
pulisher
Sep 23, 2024

An Analysis of Theravance Biopharma Inc (TBPH)’s Potential Price Growth - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Theravance Biopharma settles patent litigation with Qilu Pharmaceutical - Investing.com

Sep 23, 2024
pulisher
Sep 21, 2024

Baupost Group LLC MA Decreases Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat

Sep 21, 2024
pulisher
Sep 17, 2024

Theravance Biopharma (NASDAQ:TBPH) Given “Buy” Rating at HC Wainwright - Defense World

Sep 17, 2024
pulisher
Sep 16, 2024

H.C. Wainwright maintains Buy rating on Theravance Biopharma shares By Investing.com - Investing.com Canada

Sep 16, 2024
pulisher
Sep 16, 2024

Theravance Biopharma (NASDAQ:TBPH) Earns Buy Rating from HC Wainwright - MarketBeat

Sep 16, 2024
pulisher
Sep 16, 2024

Unveiling 4 Analyst Insights On Theravance Biopharma - Benzinga

Sep 16, 2024
pulisher
Sep 11, 2024

How To Trade (TBPH) - Stock Traders Daily

Sep 11, 2024
pulisher
Sep 11, 2024

Leerink Partners gives a Market perform recommendation for Theravance Biopharma Inc (TBPH) - Knox Daily

Sep 11, 2024
pulisher
Sep 10, 2024

Seth Klarman's Complete Exit from Theravance Biopharma Inc - Yahoo Finance

Sep 10, 2024
pulisher
Sep 10, 2024

Theravance Biopharma Outlines Growth Strategy at Investment Conference - TipRanks

Sep 10, 2024
pulisher
Sep 06, 2024

Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation - Yahoo Finance

Sep 06, 2024
pulisher
Sep 04, 2024

Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Sep 04, 2024
pulisher
Sep 02, 2024

Theravance Biopharma Inc (TBPH) receives a Market perform rating from Leerink Partners - Knox Daily

Sep 02, 2024
pulisher
Aug 31, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Rating of “Hold” by Analysts - Defense World

Aug 31, 2024
pulisher
Aug 31, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives $13.75 Consensus Target Price from Analysts - MarketBeat

Aug 31, 2024
pulisher
Aug 28, 2024

Q3 2024 EPS Estimates for Theravance Biopharma, Inc. (NASDAQ:TBPH) Reduced by Analyst - MarketBeat

Aug 28, 2024
pulisher
Aug 27, 2024

Theravance Biopharma (NASDAQ:TBPH) Shares Pass Below 50-Day Moving Average of $8.90 - MarketBeat

Aug 27, 2024
pulisher
Aug 27, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) to Post Q4 2025 Earnings of $0.41 Per Share, Zacks Research Forecasts - Defense World

Aug 27, 2024
pulisher
Aug 27, 2024

Zacks Research Brokers Increase Earnings Estimates for Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat

Aug 27, 2024
pulisher
Aug 27, 2024

Theravance Biopharma to Participate in an Upcoming Investor Conference - Citizentribune

Aug 27, 2024
pulisher
Aug 27, 2024

Theravance Biopharma (NASDAQ:TBPH) Stock Crosses Below Fifty Day Moving Average of $8.90 - Defense World

Aug 27, 2024
pulisher
Aug 22, 2024

TBPH Stock Earnings: Theravance Biopharma Beats EPS, Misses Revenue for Q2 2024 - MSN

Aug 22, 2024
pulisher
Aug 21, 2024

Leerink Partners Downgrades Theravance Biopharma Inc (TBPH) to a Market perform from an Outperform - Knox Daily

Aug 21, 2024

Theravance Biopharma Inc (TBPH) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Theravance Biopharma Inc 주식 (TBPH) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Jul 10 '24
Sale
9.00
4,000
36,000
335,965
Samaha Eli
10% Owner
May 01 '24
Buy
8.75
1,499,124
13,117,335
8,511,350
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Feb 22 '24
Sale
8.71
1,254
10,922
311,733
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Nov 21 '23
Sale
10.29
1,378
14,180
331,206
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Nov 14 '23
Sale
10.22
2,482
25,366
346,839
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):